AIDS CLINICAL TRIAL GROUP A5079

艾滋病临床试验组 A5079

• 批准号: 7375893
• 负责人: JENNIFER BALFOUR
• 金额: $ 0.25万
• 依托单位: UNIVERSITY OF MINNESOTA
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7375893
• 关键词: AIDS; CLINICAL; TRIAL; GROUP; A5079

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study will test the hypothesis that the change in viseral fat (in a cross-sectional area) will be greater with testosterone replacement than with placebo in HIV-positive men who are noted to have abdominal obesity and who have mildly to moderately reduced serum testosterone levels. The GCRC will be asked to perform DEXA scans on subjects who agree to participate in this trial.

该子项目是利用 NIH/NCRR 资助的中心拨款提供的资源的众多研究子项目之一。子项目和研究者 (PI) 可能已从另一个 NIH 来源获得主要资金，因此可以在其他 CRISP 条目中得到体现。列出的机构是中心的机构，不一定是研究者的机构。这项研究将检验这样一个假设：对于患有腹部肥胖且血清睾酮水平轻度至中度降低的艾滋病毒阳性男性，睾酮替代疗法比安慰剂组内脏脂肪（横截面面积）的变化更大。 GCRC 将被要求对同意参加本试验的受试者进行 DEXA 扫描。